Aprea Therapeutics, Inc. (APRE): SCHEDULE 13G/A filed Aug 13, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 13, 2026

Accession number

0000935836-26-000399

Filer

Aprea Therapeutics, Inc. (CIK 1781983)